The aberrant activation of signaling cascades mediated by insulin and the insulin-like growth factor (IGF) family has been implicated in the pathophysiology of numerous ailments, including diabetes, cancer, obesity, neurodegenerative disorders, and musculoskeletal conditions (30–33). The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.